Zeitschrift
Investigational New Drugs
Novel Anti-Cancer Therapeutics and Therapies
-
PHASE II STUDIESEffectiveness and safety of eribulin in Japanese patients with HER2-negative, advanced breast cancer: a 2-year post-marketing observational study in a real-world setting
-
Short ReportPatient selection for a developmental therapeutics program using whole genome and Transcriptome analysis
-
PRECLINICAL STUDIESSorafenib may enhance antitumour efficacy in hepatocellular carcinoma patients by modulating the proportions and functions of natural killer cells
-
Short ReportEfficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience